ERBB2 and metastatic malignant neoplasm in the lymph nodes: Despite our study suggested no significant association between ER/PR Her2 status and lymph node involvement, molecular markers have been widely evaluated and various studies have assessed the role of ER and PR receptors status in predicting axillary lymph node metastasis with initial conflicting results.